3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
104
Lung Neoplasms
40
Neoplasm Metastasis
13
Neoplasms
12
Colorectal Neoplasms
10
Pancreatic Neoplasms
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Carcinoma
6
Mesothelioma, Malignant
5
Mesothelioma
5
Colonic Neoplasms
5
Ovarian Neoplasms
4
Meningeal Carcinomatosis
4
Melanoma
4
Advanced Solid Tumors
4
Rectal Neoplasms
3
Neoplasms by Site
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Non-squamous Non-small Cell Lung Cancer
2
Lung Diseases
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Bronchogenic
2
Bronchial Neoplasms
2
Brain Neoplasms
2
Interventions
pegaspargase
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Asparaginase
2
tislelizumab
1
sugemalimab
1
selinexor
1
pembrolizumab
1
fludarabine
1
Vorinostat
1
Transplantation
1
Tomography, X-Ray Computed
1
Sirolimus
1
Methylprednisolone
1
Methotrexate
1
Melphalan
1
IMC-001
1
Cyclosporine
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Pemetrexed
×
90 days
×
Clear all
No trials found.